Article info
PDFExtended reports
A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate
- Correspondence to:
Dr S B Cohen
Department of Rheumatology, St Paul Medical Center, 5939 Harry Hines Blvd, Suite 400, Dallas, TX 75235, USA; stanleycohenradiantresearch.net
Citation
A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate
Publication history
- Accepted February 19, 2004
- First published April 13, 2004.
Online issue publication
August 12, 2004
Article Versions
- Previous version (13 April 2004).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2004 by Annals of the Rheumatic Diseases